Background: A wealth of experimental and epidemiological evidence suggest that Apolipoprotein A-I (ApoA-I), the main protein constituent of high-density lipoprotein (HDL), may protect against Alzheimer disease (AD). This evidence concerns the gene APOA1 and early-onset autosomal dominant Alzheimer disease.